RecruitingNCT03755726
A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
Sponsor
Centre Hospitalier de PAU
Enrollment
1,200 participants
Start Date
Sep 20, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Malignant hypertension according to the classic definition (Severe hypertension, above 180/110 associated with severe hypertensive retinopathy)
- Severe hypertension (above 180/110) associated with acute damage of 3 target organ due to high blood pressure
Exclusion Criteria3
- Age \< 18 years old
- Patients who cannot freely give their consent, or patients who refuse to participate
- Dialysis
Locations(37)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03755726